RDY 6-K 2026 - Equibles

SECURITIES AND EXCHANGE COMMISSION

Washington,D.C. 20549

Form 6-K

REPORTOF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

June, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337,Road No. 3, Banjara Hills

Hyderabad,Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

**Note:**Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits

99.1		Intimation dated June 30, 2026

| 2 |

| --- |

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED<br><br><br><br>(Registrant)
Date: June 30, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

| 3 |

| --- |

Exhibit99.1

	Dr. Reddy’s Laboratories Ltd.<br><br> <br>8-2-337, Road No. 3, Banjara Hills<br><br> <br>Hyderabad<br> – 500 034, Telangana, India<br><br> <br><br><br> <br>CIN:<br> L85195TG1984PLC004507<br><br> <br><br><br> <br>Tel: +<br> 91 40 4900 2900<br><br> <br>Fax: +<br> 91 40 4900 2999<br><br> <br>Email: <br> [email protected]<br><br> <br>Web:<br> www.drreddys.com

June 30, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Sub:Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI ListingRegulations”) – Letter to shareholders in relation to Integrated Annual Report of the Company for FY2025-26

Pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, letters are being sent to those shareholders who have not registered their email addresses with the Company or the Registrar and Share Transfer Agent or the Depository Participant(s), providing the weblink for accessing the Notice of the 42^nd^ Annual General Meeting and Integrated Annual Report of the Company for the financial year 2025-26.

The above referred letter in this regard is enclosed. You are requested to take the above information on record.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

CompanySecretary, Compliance Officer and Head-CSR

	Dr. Reddy’s Laboratories Limited<br><br> <br>CIN: L85195TG1984PLC004507<br><br> <br>Registered Office: 8-2-337, Road No. 3, Banjara Hills,<br><br> <br>Hyderabad – 500 034, Telangana, India.<br><br> <br>Tel : +91 40 49002900, Fax : +91 40 49002999<br><br> <br>**Email : [email protected]	Website : www.drreddys.com**
42^nd^ Annual General Meeting
---

We are pleased to inform you that the 42^nd^<br> Annual General Meeting (“AGM”) of the Company will be held on Thursday, July 23, 2026, at 11:00 a.m. (1ST) through Video<br> Conferencing (“VC”)/Other Audio Visual Means (“OAVM”).

The<br> Notice and Integrated Annual Report for Financial Year 2025-26 is available and can be downloaded from below link and QR code: https://www.drreddys.com/cms/sites/default/files/2026-06/Integrated<br> Annual Report 2025-26.pdf


Final Dividend for FY 2025-26:
---	---
Amount<br> of Dividend	₹8<br> per equity share
Record<br> date	Friday,<br> July 10, 2026
Payment<br> date	On<br> or before July 30, 2026
You are requested to update and complete<br> your KYC* details with:
---

· Depository Participants<br>(DPs), if shares held in electronic form:

·<br>Company I Registrar and Transfer Agent (“RTA”) through Service request, if shares held in physical form:

*(including name, postal address, email ID, telephone/mobile numbers, PAN, mandates, nominations, power of attorney and Bank Details)
E-voting Details:
---	---
Cut-off<br> date to determine entitlement for e-voting	Thursday,<br> July 16, 2026
E-voting<br> start date and time	Sunday,<br> July 19, 2026 (9:00 a.m. IST)
E-voting<br> end date and time	Wednesday,<br> July 22, 2026 (5:00 p.m. IST)
Refer to instructions for Members for Attending the EGM/AGM Through VC/OAVM of 42^nd^ AGM Notice to know the procedure for Speaker registration, e-voting and to join virtual AGM
---

Members who are attending the AGM and have not cast their vote during remote e-voting period, can vote on the resolutions during the AGM
Correspondence/Queries:
All<br>queries to be addressed to the Company’s RTA:<br><br><br><br>Bigshare<br>Services Private Limited<br><br><br><br>Unit<br>- Dr. Reddy’s Laboratories Limited<br><br><br><br>306,<br>Right Wing, 3rd Floor, Amrutha Ville,<br><br><br><br>Opp.<br>Yashoda Hospital, Rajbhavan Road, Hyderabad 500 082, Telangana, India.<br><br><br><br>Tel:<br>+91-40-2337 4967, 4014 4967<br><br><br><br>You<br>may also send service request to email id [email protected]

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

Sd/

KRandhir Singh

Company Secretary, Compliance Officer & Head-CSR

Membership Number: F6621